Clinical Trials Directory

Trials / Unknown

UnknownNCT04581746

Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,800 (estimated)
Sponsor
Tourcoing Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into "teleconsultation" or exchanges of e-mails between practitioners and patients during COVID-19 epidemic. This change in care can have an impact on follow-up and access to treatment for PVVIH.

Detailed description

On 16 March 2020, an instruction to postpone "non-urgent" consultations was given to doctors. Thus, the non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into "teleconsultation" or exchanges of e-mails between practitioners and patients. This change in care can have an impact on follow-up and access to treatment for PVVIH. In addition, the epidemic itself may have consequences: PVVIH may be at greater risk because of their immunosuppression and associated co-morbidities.

Conditions

Interventions

TypeNameDescription
OTHERquestionnairebi-monthly questionnaire and then one visit with questionnaire and covid-19 test

Timeline

Start date
2020-11-25
Primary completion
2022-06-01
Completion
2022-12-01
First posted
2020-10-09
Last updated
2022-05-10

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04581746. Inclusion in this directory is not an endorsement.